Drug-Screening Strategies for Inhibition of Virus-Induced Neuronal Cell Death

A number of viruses, including Herpes Simplex Virus (HSV), West Nile Virus (WNV), La Crosse Virus (LACV), Zika virus (ZIKV) and Tick-borne encephalitis virus (TBEV), have the ability to gain access to the central nervous system (CNS) and cause severe neurological disease or death. Although encephali...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Durbadal Ojha, Tyson A. Woods, Karin E. Peterson
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/bd32a25a0ae14c0bad832bb26e148f19
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bd32a25a0ae14c0bad832bb26e148f19
record_format dspace
spelling oai:doaj.org-article:bd32a25a0ae14c0bad832bb26e148f192021-11-25T19:14:31ZDrug-Screening Strategies for Inhibition of Virus-Induced Neuronal Cell Death10.3390/v131123171999-4915https://doaj.org/article/bd32a25a0ae14c0bad832bb26e148f192021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4915/13/11/2317https://doaj.org/toc/1999-4915A number of viruses, including Herpes Simplex Virus (HSV), West Nile Virus (WNV), La Crosse Virus (LACV), Zika virus (ZIKV) and Tick-borne encephalitis virus (TBEV), have the ability to gain access to the central nervous system (CNS) and cause severe neurological disease or death. Although encephalitis cases caused by these viruses are generally rare, there are relatively few treatment options available for patients with viral encephalitis other than palliative care. Many of these viruses directly infect neurons and can cause neuronal death. Thus, there is the need for the identification of useful therapeutic compounds that can inhibit virus replication in neurons or inhibit virus-induced neuronal cell death. In this paper, we describe the methodology to test compounds for their ability to inhibit virus-induced neuronal cell death. These protocols include the isolation and culturing of primary neurons; the culturing of neuroblastoma and neuronal stem cell lines; infection of these cells with viruses; treatment of these cells with selected drugs; measuring virus-induced cell death using MTT or XTT reagents; analysis of virus production from these cells; as well as the basic understanding in mode of action. We further show direct evidence of the effectiveness of these protocols by utilizing them to test the effectiveness of the polyphenol drug, Rottlerin, at inhibiting Zika virus infection and death of neuronal cell lines.Durbadal OjhaTyson A. WoodsKarin E. PetersonMDPI AGarticleencephalitic virusneuronal cell linesdrug screencytotoxicity concentrationeffective concentrationselectivity indexMicrobiologyQR1-502ENViruses, Vol 13, Iss 2317, p 2317 (2021)
institution DOAJ
collection DOAJ
language EN
topic encephalitic virus
neuronal cell lines
drug screen
cytotoxicity concentration
effective concentration
selectivity index
Microbiology
QR1-502
spellingShingle encephalitic virus
neuronal cell lines
drug screen
cytotoxicity concentration
effective concentration
selectivity index
Microbiology
QR1-502
Durbadal Ojha
Tyson A. Woods
Karin E. Peterson
Drug-Screening Strategies for Inhibition of Virus-Induced Neuronal Cell Death
description A number of viruses, including Herpes Simplex Virus (HSV), West Nile Virus (WNV), La Crosse Virus (LACV), Zika virus (ZIKV) and Tick-borne encephalitis virus (TBEV), have the ability to gain access to the central nervous system (CNS) and cause severe neurological disease or death. Although encephalitis cases caused by these viruses are generally rare, there are relatively few treatment options available for patients with viral encephalitis other than palliative care. Many of these viruses directly infect neurons and can cause neuronal death. Thus, there is the need for the identification of useful therapeutic compounds that can inhibit virus replication in neurons or inhibit virus-induced neuronal cell death. In this paper, we describe the methodology to test compounds for their ability to inhibit virus-induced neuronal cell death. These protocols include the isolation and culturing of primary neurons; the culturing of neuroblastoma and neuronal stem cell lines; infection of these cells with viruses; treatment of these cells with selected drugs; measuring virus-induced cell death using MTT or XTT reagents; analysis of virus production from these cells; as well as the basic understanding in mode of action. We further show direct evidence of the effectiveness of these protocols by utilizing them to test the effectiveness of the polyphenol drug, Rottlerin, at inhibiting Zika virus infection and death of neuronal cell lines.
format article
author Durbadal Ojha
Tyson A. Woods
Karin E. Peterson
author_facet Durbadal Ojha
Tyson A. Woods
Karin E. Peterson
author_sort Durbadal Ojha
title Drug-Screening Strategies for Inhibition of Virus-Induced Neuronal Cell Death
title_short Drug-Screening Strategies for Inhibition of Virus-Induced Neuronal Cell Death
title_full Drug-Screening Strategies for Inhibition of Virus-Induced Neuronal Cell Death
title_fullStr Drug-Screening Strategies for Inhibition of Virus-Induced Neuronal Cell Death
title_full_unstemmed Drug-Screening Strategies for Inhibition of Virus-Induced Neuronal Cell Death
title_sort drug-screening strategies for inhibition of virus-induced neuronal cell death
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/bd32a25a0ae14c0bad832bb26e148f19
work_keys_str_mv AT durbadalojha drugscreeningstrategiesforinhibitionofvirusinducedneuronalcelldeath
AT tysonawoods drugscreeningstrategiesforinhibitionofvirusinducedneuronalcelldeath
AT karinepeterson drugscreeningstrategiesforinhibitionofvirusinducedneuronalcelldeath
_version_ 1718410120154578944